Sequential 2.5 mg letrozole/FSH therapy is more effective for promoting pregnancy in infertile women with PCOS: a pragmatic randomized controlled trial

Overview of attention for article published in Frontiers in endocrinology, January 2024

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Good Attention Score compared to outputs of the same age and source (78th percentile)

Mentioned by

twitter: 4 X users

Citations

dimensions_citation: 1 Dimensions

Readers on

mendeley: 14 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 6,467 followers.

RT @FrontEndocrinol: New Research: Sequential 2.5 mg letrozole/FSH therapy is more effective for promoting pregnancy in infertile women wit…

14 Jan 2024

Reply Repost Favourite

RT @FrontEndocrinol: New Research: Sequential 2.5 mg letrozole/FSH therapy is more effective for promoting pregnancy in infertile women wit…

13 Jan 2024

Reply Repost Favourite

RT @FrontEndocrinol: New Research: Sequential 2.5 mg letrozole/FSH therapy is more effective for promoting pregnancy in infertile women wit…

13 Jan 2024

Reply Repost Favourite

New Research: Sequential 2.5 mg letrozole/FSH therapy is more effective for promoting pregnancy in infertile women with PCOS: a pragmatic randomized controlled trial: Study question In infertile women with polycystic ovary syndrome… https://t.co/0IXDLUXQT

13 Jan 2024

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.